Annexon, Inc. (NASDAQ:ANNX) Shares Purchased by State Street Corp

State Street Corp raised its stake in Annexon, Inc. (NASDAQ:ANNX) by 116.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,841,879 shares of the company’s stock after purchasing an additional 2,068,294 shares during the quarter. State Street Corp’s holdings in Annexon were worth $22,744,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Candriam S.C.A. acquired a new position in Annexon in the second quarter valued at $10,061,000. Sio Capital Management LLC purchased a new position in shares of Annexon in the 3rd quarter worth about $8,484,000. Marshall Wace LLP lifted its stake in shares of Annexon by 436.6% in the 2nd quarter. Marshall Wace LLP now owns 1,693,665 shares of the company’s stock valued at $8,299,000 after purchasing an additional 1,378,053 shares in the last quarter. Point72 Asset Management L.P. grew its holdings in shares of Annexon by 16.1% during the 2nd quarter. Point72 Asset Management L.P. now owns 5,989,017 shares of the company’s stock worth $29,346,000 after purchasing an additional 832,617 shares during the period. Finally, Mutual of America Capital Management LLC acquired a new stake in Annexon during the 2nd quarter worth approximately $3,134,000.

Insider Buying and Selling at Annexon

In other Annexon news, EVP Ted Yednock sold 5,408 shares of Annexon stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $7.41, for a total transaction of $40,073.28. Following the sale, the executive vice president now directly owns 71,365 shares in the company, valued at $528,814.65. The trade was a 7.04 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 12.67% of the stock is currently owned by corporate insiders.

Annexon Trading Up 0.2 %

Shares of ANNX stock opened at $5.23 on Monday. The firm has a fifty day simple moving average of $6.17 and a 200-day simple moving average of $5.97. The company has a market capitalization of $557.49 million, a PE ratio of -4.98 and a beta of 1.10. Annexon, Inc. has a twelve month low of $3.27 and a twelve month high of $8.40.

Analyst Ratings Changes

Several equities research analysts have issued reports on ANNX shares. Cantor Fitzgerald reiterated an “overweight” rating on shares of Annexon in a research note on Friday, November 15th. HC Wainwright reaffirmed a “buy” rating and set a $30.00 price target on shares of Annexon in a research report on Tuesday, December 17th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $16.00 price objective on shares of Annexon in a research report on Friday, November 15th. Six analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $15.80.

About Annexon

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.